Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies (Q37118932)

18 August 2017

1 reference

title

Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies (English)

1 reference

18 August 2017

1 reference

Steven H Lin

1

1 reference

18 August 2017

Lawrence R Kleinberg

series ordinal

2

1 reference

18 August 2017

publication date

1 March 2008

1 reference

Expert Review of Anticancer Therapy

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

3

1 reference

18 August 2017

page(s)

343-359

1 reference

Recent advances in the treatment of malignant astrocytoma

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Genetic pathways to glioblastoma: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

25-year study of lung fibrosis following carmustine therapy for brain tumor in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Evaluation of a total scalp electron irradiation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Pharmacokinetics of the carmustine implant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Excretion of a radiolabelled anticancer biodegradable polymeric implant from the rabbit brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Interstitial chemotherapy of experimental brain tumors: comparison of intratumoral injection versus polymeric controlled release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Temozolomide: a milestone in neuro-oncology and beyond?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Brain biocompatibility of a biodegradable, controlled-release polymer in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Biodegradable polymers for controlled delivery of chemotherapy with and without radiation therapy in the monkey brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Tumor bed cyst formation after BCNU wafer implantation: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Management of tumor bed cysts after chemotherapeutic wafer implantation. Report of four cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

The management of brain edema in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Dose escalation of carmustine in surgically implanted polymers in patients with recurrent malignant glioma: a New Approaches to Brain Tumor Therapy CNS Consortium trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Local delivery of chemotherapy prolongs survival in experimental brain metastases from breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Treatment of single brain metastasis with resection, intracavity carmustine polymer wafers, and radiation therapy is safe and provides excellent local control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Gliadel for pituitary adenomas and craniopharyngiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Intracavitary chemotherapy (Gliadel) for recurrent esthesioneuroblastoma: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Inactivation of O6-alkylguanine DNA alkyltransferase as a means to enhance chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Phase I trial of polifeprosan 20 with carmustine implant plus continuous infusion of intravenous O6-benzylguanine in adults with recurrent malignant glioma: new approaches to brain tumor therapy CNS consortium trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Local delivery of antineoplastic agents by controlled-release polymers for the treatment of malignant brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Local delivery of a synthetic endostatin fragment for the treatment of experimental gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Radiosensitization of a mouse tumor model by sustained intra-tumoral release of etanidazole and tirapazamine using a biodegradable polymer implant device

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Local chemotherapy with cisplatin-depot for glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Lactacystin exhibits potent anti-tumor activity in an animal model of malignant glioma when administered via controlled-release polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Local delivery of mitoxantrone for the treatment of malignant brain tumors in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Interstitial docetaxel (taxotere), carmustine and combined interstitial therapy: a novel treatment for experimental malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Therapeutic efficacy study of novel 5-FU-loaded PMM 2.1.2-based microspheres on C6 glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

Targeted therapy for brain tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.8.3.343

21 January 2018

Identifiers

DOI

10.1586/14737140.8.3.343

1 reference

18 August 2017

1 reference